Evidence map›Paper›PMID 39938724›Full record

ArticlePreventive medicine2025

Alcohol, Cannabis, and nicotine use during early pregnancy and infant hearing loss.

Kelly C Young-Wolff, Nina Oberman, Stacey E Alexeeff, Lisa A Croen, Kristin R Steuerle, Deborah Ansley, Carley Castellanos, Lyndsay A Avalos

Abstract read
In one paragraph

Article in Preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Substance and alcohol use in pregnant women attending antenatal care at a tertiary hospital in Johannesburg, South Africa.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kelly C Young-WolffDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, United States of America; Department of Health Systems Science, Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, United States of America. Electronic address: Kelly.c.young-wolff@kp.org.
Nina ObermanDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.
Stacey E AlexeeffDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.
Lisa A CroenDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America; Department of Health Systems Science, Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, United States of America.
Kristin R SteuerleKaiser Permanente Santa Rosa Medical Center, Santa Rosa, CA, United States of America.
Deborah AnsleyThe Permanente Medical Group, Regional Offices, Pleasanton, CA, United States of America.
Carley CastellanosThe Permanente Medical Group, Regional Offices, Pleasanton, CA, United States of America.
Lyndsay A AvalosDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America; Department of Health Systems Science, Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, CA, United States of America.

Funding

Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort StudyR01DA047405 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI AVALOS, LYNDSAY AMMON, YOUNG-WOLFF, KELLY CORINNE · 2019 to 2023
$3.5M
Impact of in utero Marijuana Exposure on Neurodevelopment, Behavior and Mental Health: A Longitudinal Birth Cohort StudyR01DA048033 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI AVALOS, LYNDSAY AMMON, YOUNG-WOLFF, KELLY CORINNE · 2020 to 2025
$3.1M
Modes of Cannabis Administration and Polysubstance Use among Women Before and During PregnancyR01DA058201 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Kelly Corinne Young-Wolff · 2023 to 2026
$2.6M
Identifying Risk Factors for Prenatal Substance and Polysubstance UseK01DA043604 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI YOUNG-WOLFF, KELLY CORINNE · 2017 to 2021
$907k
NIDA NIH HHS K01 DA043604NIDA NIH HHS R01 DA047405NIDA NIH HHS R01 DA048033NIDA NIH HHS R01 DA058201
6 · The paper itself

Abstract

objectiveTo examine whether maternal prenatal alcohol, cannabis, or nicotine use was associated with offspring diagnoses of hearing loss during the first six months of life.

methodsWe conducted a population-based retrospective birth cohort study of infants (N = 297,147) born between 2011 and 2023 to pregnant individuals (N = 233,902) in Kaiser Permanente Northern California universally screened for any prenatal alcohol, cannabis, or nicotine use since pregnancy at entrance to prenatal care (at ∼8-10 weeks gestation). Offspring hearing loss was defined as ≥1 hearing loss diagnosis in the infant's electronic health record based on ICD codes. Modified Poisson regression models for binary data were used to estimate the risk ratio (RR) of infant hearing loss by each prenatal substance adjusting for covariates.

resultsThe sample of pregnancies were to 23.9 % Asian/Pacific Islander, 5.3 % Black, 26.1 % Hispanic, and 37.7 % non-Hispanic White individuals, with a mean (SD) age of 32 (5.4) years; 9.9 % screened positive for any alcohol use during early pregnancy, 5.6 % screened positive for any cannabis use during early pregnancy, and 3.9 % screened positive for any nicotine use during early pregnancy. Overall, 0.2 % of infants had a hearing loss diagnosis during the first six months of life. In fully adjusted models, prenatal alcohol use (adjusted RR:1.37; 95 %CI:1.05-1.79) but not prenatal cannabis or nicotine use, was associated with increased risk of infant hearing loss.

conclusionsMaternal alcohol use during early pregnancy was associated with an increased risk of offspring diagnoses of hearing loss during the first six months of life.

Indexed as

Alcohol DrinkingHearing LossNicotinePrenatal Exposure Delayed EffectsAdultCaliforniaCannabisFemaleHumansInfantInfant, NewbornMalePregnancyRetrospective StudiesRisk FactorsNicotineAlcoholCannabisHearing lossMarijuanaNicotinePregnancyPrenatal substance use

Identifiers

PMID39938724
PMCPMC11884327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.